NCT06212544

Brief Summary

The aim is the current study is to establish feasibility and acceptability of the SeCuRE intervention to improve HIV prevention and care continua outcomes. To meet this aim, the study has the following objectives:

  1. 1.To deliver a two-armed pilot RCT of the SeCuRE intervention with 40 transgender women of color.
  2. 2.The determine acceptability of the intervention with transgender women of color.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 19, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

June 7, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2025

Completed
3 months until next milestone

Results Posted

Study results publicly available

June 5, 2025

Completed
Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

December 20, 2023

Results QC Date

May 19, 2025

Last Update Submit

June 4, 2025

Conditions

Keywords

TransgenderHIVmicroeconomic

Outcome Measures

Primary Outcomes (1)

  • Acceptability Quantitative

    The Client Satisfaction Questionnaire (CSQ-8) will be used to assess intervention satisfaction. This is an 8-item scale where each individual item is scored separately with a range of 1 to 4 and a score of 3 or 4 on each item will be considered indicative of acceptable.

    3 months

Study Arms (2)

Immediate Intervention

EXPERIMENTAL

The intervention condition builds on our community partners' existing microeconomic intervention of: (1) a one-time emergency cash grant and (2) peer and legal support to obtain legal gender affirmation - plus a 12-week microeconomic intervention that adds: (3) weekly educational sessions and HIV prevention; (4) community mentoring; and (5) weekly posts of job openings in Detroit; and (6) a micro-grant for use towards acquiring self-led or formal employment

Behavioral: Immediate Intervention

Delayed Arm

ACTIVE COMPARATOR

Participants randomized to the control condition will receive UC during the 12-week period following randomization. Usual care consists of emergency assistance and access to legal name/gender marker change. After the RCT follow-up period is complete, waitlist control participants will be offered delayed access to the same intervention that is provided immediately to intervention arm participants.

Behavioral: Delayed Intervention

Interventions

Enhanced microeconomic intervention

Immediate Intervention

Usual care and then access to enhanced microeconomic intervention

Delayed Arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • at least 18 years old;
  • assigned male at birth;
  • self identifies as female, transgender woman, or another feminine gender identity;
  • self identifies as a person of color (i.e., any racial/ethnic identity except non-Hispanic white);
  • reports earning less than $32,800 gross annual income (current living wage in Michigan);
  • reports condomless sex in the past 6 months;
  • lives in Detroit, MI greater metropolitan area (\~50 mile radius);
  • speaks English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruth Ellis Center

Highland Park, Michigan, 48203, United States

Location

Related Publications (1)

  • Gamarel K, Mayo-Wilson LJ, Jadwin-Cakmak L, Reyes L, Monro D, Ubong IA, Sullivan S, Abad J, Poindexter J, Harris H, Riser C, Stephenson J, Ortiz G, Peitzmeier SM, Neilands TB, Poteat T. Strengthening Community Responses to Economic vulnerability (SeCuRE): a protocol of an HIV status-neutral pilot randomized clinical trial with transgender women of color in Detroit, Michigan. Pilot Feasibility Stud. 2024 Nov 8;10(1):135. doi: 10.1186/s40814-024-01558-5.

Results Point of Contact

Title
Kristi Gamarel
Organization
University of Michigan

Study Officials

  • Kristi Gamarel, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Pilot waitlist randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Health Behavior and Health Education

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 19, 2024

Study Start

June 7, 2024

Primary Completion

February 26, 2025

Study Completion

February 26, 2025

Last Updated

June 5, 2025

Results First Posted

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

The investigators plan to share de-identified data per guidelines; however, data will be in aggregate form to ensure individuals are not identified in anyway.

Locations